- Home
- CNDT vs NVCT Comparison
CNDT vs NVCT Comparison
Compare CNDT & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNDT | NVCT |
|---|---|---|
| Founded | 2016 | 2020 |
| Country | United States | United States |
| Employees | 51000 | N/A |
| Industry | Business Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.4M | 220.0M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CNDT | NVCT |
|---|---|---|
| Price | $1.71 | $8.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 1.2M | 47.8K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,042,000,000.00 | N/A |
| Revenue This Year | $2.01 | N/A |
| Revenue Next Year | $4.06 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $5.55 |
| 52 Week High | $2.98 | $11.52 |
Technical Indicators
Market Signals| Indicator | CNDT | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 66.15 | 58.59 |
| Support Level | $1.16 | $8.03 |
| Resistance Level | $2.10 | $9.20 |
| Average True Range (ATR) | 0.10 | 0.43 |
| MACD | 0.03 | 0.10 |
| Stochastic Oscillator | 73.20 | 80.49 |
Price Performance
Historical ComparisonAbout CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.